About this episode
Earlier this month, President Donald Trump announced the U.S. would impose up to a 200% tariff on imported pharmaceuticals , though he would give them up to a year and a half before fully implementing the tariffs . Trump’s goal is to bring more manufacturing to the United States, but one pharmaceutical CEO, Richard Saynor of Sandoz, says there is little incentive to build in the U.S . Jessica Mendoza hosts. Further Listening: - Why Trump Pushed His Tariff Deadline - Inside the Surprise U.S.-China Trade Deal Sign up for WSJ’s free What’s News newsletter . Learn more about your ad choices. Visit megaphone.fm/adchoices